Role of p38 mitogen-activated protein kinase in trauma/hemorrhage and subsequent peumococcal pneumonia

N. Ding, K. Dahlke, A. K. Janze, P. Mailer, T. Welte, N. C. Riedemann, U. A. Maus (Germany)

Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Session: Aetiology of lower respiratory tract infections and treatment in special situations
Session type: Thematic Poster Session
Number: 2996
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Ding, K. Dahlke, A. K. Janze, P. Mailer, T. Welte, N. C. Riedemann, U. A. Maus (Germany). Role of p38 mitogen-activated protein kinase in trauma/hemorrhage and subsequent peumococcal pneumonia. Eur Respir J 2010; 36: Suppl. 54, 2996

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs
Source: Eur Respir J 2013; 42: 28-41
Year: 2013



Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids
Source: Eur Respir J 2011; 37: 933-942
Year: 2011



Ventilation-induced activation of the mitogen-activated protein kinase pathway
Source: Eur Respir J 2002; 20: 946-956
Year: 2002



Effect of fudosteine on mucin production
Source: Eur Respir J 2008; 32: 1195-1202
Year: 2008



The effects of oral p38 mitogen activated protein kinase (MAPK) inhibitor SB-681323 on blood biomarkers in COPD
Source: Annual Congress 2008 - Novel treatments for respiratory disease
Year: 2008


p38 MAPK inhibitors in COPD
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012

Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure
Source: Eur Respir J 2005; 25: 797-803
Year: 2005



Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia: role of p38 MAP kinase
Source: Eur Respir J 2001; 18: Suppl. 33, 73s
Year: 2001

LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


c-Jun N-terminal kinase-dependent mechanisms in respiratory disease
Source: Eur Respir J 2006; 28: 651-661
Year: 2006



Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages
Source: Eur Respir J 2004; 23: 805-812
Year: 2004



p38 MAP kinase mediates apoptosis related to ventilator associated lung injury
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008

Role of c-Jun N-terminal kinase in human eosinophil apoptosis
Source: Eur Respir J 2004; 24: Suppl. 48, 36s
Year: 2004

Constitutive phosphorylation of p38 mitogen activated protein kinase controls proliferation of mesothelioma cells
Source: Eur Respir J 2005; 26: Suppl. 49, 225s
Year: 2005

Inhibition of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase prevents malignant pleural mesothelioma cell growth
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001